A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2016; you can also visit the original URL.
The file type is
Zolpidem, a Schedule IV controlled substance under the Federal Controlled Substance Act, has a rapid onset of action and short elimination half-life, rendering it ideal as a sleep aid. The crossreactivity of two zolpidem ELISA kits was investigated using patients taking a known administration of zolpidem. Subjects provided urine samples before, 30 min after their prescribed dose, and upon waking. Specimens were screened for zolpidem by ELISA (Immunalysis and Neogen) and then confirmed anddoi:10.1093/anatox/35.5.294 pmid:21619724 fatcat:il3hbi3sqrcorgjracdw3tpgni